ABSTRACT
The studies were carried out in 1999-2001 at Clinical Institute (Former: Institute for Experimental Clinical Research) and at the department of Cardiac Thoracic and Vascular Surgery, Skejby Sygehus, Aarhus University Hospital, Denmark.
The PhD dissertation was compiled from three studies.
I: The aim was to test and describe the effect of right heart assistance for coronary artery bypass grafting in an animal experimental model. The heart was dislocated in order to allow access to the marginal arteries. The haemodynamics were monitored with and without application of right heart assistance.
II: Based on the positive results from study I, the aim of the second study was to implement right heart assistance technique in a clinical setting and compare the results with coronary bypass surgery performed with cardiopulmonary bypass in the same period at the same clinic. Fifty patients operated on with right heart assistance and 50 patients operated on with cardiopulmonary bypass were investigated.
III: The aim was to investigate whether low molecular weight heparin can prevent a suspected procoagulant state after coronary artery bypass grafting using right heart assistance.
The results are interpreted as follows. Coronary artery bypass surgery targeting the marginal arteries can be performed without the use of cardiopulmonary bypass. Stable haemodynamics can be achieved using right heart assistance (I and II). Approximate 20% of the patients needed additionally medical stimulation to maintain normal haemodynamic status during the surgical procedure (II). Right heart assistance for coronary artery bypass grafting is a real supplement to the variety of treatment methods that patients can be offered in heart surgery. The antithrombotic treatment strategy confined to acetylic salicylic acid only might be insufficient.